We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-6.43%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.88B
AUM Growth
-$383M
(-7.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
934
New
138
Increased
293
Reduced
289
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$40.2M |
| 2 |
Eli Lilly
LLY
|
+$37M |
| 3 |
PepsiCo
PEP
|
+$29.9M |
| 4 |
Wells Fargo
WFC
|
+$19M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$27.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$25.7M |
| 3 |
ExxonMobil
XOM
|
+$23.1M |
| 4 |
Costco
COST
|
+$22.1M |
| 5 |
Paychex
PAYX
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.87% |
| 2 | Healthcare | 16.79% |
| 3 | Technology | 16.66% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UMPQ
726
DELISTED
Umpqua Holdings Corp
UMPQ
| $163K | ﹤0.01% |
10,000
| – | – |
|
727
Arbor Realty Trust
ABR
$960M
| $162K | ﹤0.01% |
25,400
-65,464
| -72% | -$429K |
|
728
AES
AES
$10.6B
| $161K | ﹤0.01% |
+16,400
| New | +$198K |
|
|
OCLR
729
DELISTED
Oclaro Inc.
OCLR
| $161K | ﹤0.01% |
70,092
-26,900
| -28% | -$65.9K |
|
|
SMRT
730
DELISTED
Stein Mart Inc
SMRT
| $154K | ﹤0.01% |
15,904
| – | – |
|
731
FIVE9
FIVN
$1.77B
| $150K | ﹤0.01% |
40,500
+17,100
| +73% | +$77.3K |
|
732
Tilly's
TLYS
$115M
| $150K | ﹤0.01% |
20,361
+7,961
| +64% | +$69.2K |
|
733
Vishay Precision Group
VPG
$1.39B
| $144K | ﹤0.01% |
+12,400
| New | +$157K |
|
734
IRIDEX
IRIX
$15.5M
| $141K | ﹤0.01% |
+18,482
| New | +$133K |
|
|
IMGN
735
DELISTED
Immunogen Inc
IMGN
| $139K | ﹤0.01% |
14,500
-133,728
| -90% | -$1.95M |
|
|
VOLT
736
DELISTED
Volt Information Sciences, Inc.
VOLT
| $139K | ﹤0.01% |
15,300
-42,200
| -73% | -$396K |
|
737
Cumberland Pharmaceuticals
CPIX
$99M
| $138K | ﹤0.01% |
23,960
| – | – |
|
|
SQI
738
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $134K | ﹤0.01% |
+13,400
| New | +$163K |
|
739
Ocugen
OCGN
$410M
| $133K | ﹤0.01% |
+556
| New | +$201K |
|
|
STRM
740
DELISTED
Streamline Health Solutions
STRM
| $133K | ﹤0.01% |
+3,884
| New | +$157K |
|
|
SYNC
741
DELISTED
Synacor, Inc.
SYNC
| $133K | ﹤0.01% |
98,579
| – | – |
|
|
FGH
742
DELISTED
FG Group Holdings Inc.
FGH
| $131K | ﹤0.01% |
+27,842
| New | +$129K |
|
|
BCOV
743
DELISTED
Brightcove, Inc.
BCOV
| $130K | ﹤0.01% |
26,432
-54,958
| -68% | -$311K |
|
744
OraSure Technologies
OSUR
$273M
| $126K | ﹤0.01% |
28,389
-109,000
| -79% | -$569K |
|
745
A10 Networks
ATEN
$2.47B
| $125K | ﹤0.01% |
+20,800
| New | +$131K |
|
|
AHRT
746
AH Realty Trust
AHRT
$534M
| $120K | ﹤0.01% |
12,300
| – | – |
|
|
GLOG
747
DELISTED
GASLOG LTD
GLOG
| $120K | ﹤0.01% |
+12,500
| New | +$180K |
|
|
BV
748
DELISTED
Bazaarvoice, Inc.
BV
| $120K | ﹤0.01% |
26,530
-7,700
| -22% | -$41.2K |
|
|
ANTH
749
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $118K | ﹤0.01% |
2,413
-2,337
| -49% | -$163K |
|
|
INWK
750
DELISTED
InnerWorkings, Inc.
INWK
| $117K | ﹤0.01% |
18,700
-6,304
| -25% | -$44.3K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2015 Portfolio in Review
As of Q3 2015, Jacobs Levy Equity Management held 934 positions worth $4.88B, down 7.3% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q3 2015 filing shows 138 new, 293 increased, 289 reduced and 135 closed positions. Its largest new stake was Accenture: 404,880 shares worth $39.8M. The largest sale was Du Pont De Nemours E I, an estimated $27.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- Jacobs Levy Equity Management's largest Q3 2015 buy was Accenture: 404,880 shares worth $39.8M.
- Jacobs Levy Equity Management added most to Eli Lilly in Q3 2015, an estimated $37M increase.
- Jacobs Levy Equity Management's biggest Q3 2015 reduction was Du Pont De Nemours E I, cutting an estimated $27.6M.
- Jacobs Levy Equity Management fully exited HEALTH NET INC in Q3 2015, selling an estimated $16M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.88B portfolio in Q3 2015.
- Jacobs Levy Equity Management opened 138 new positions and closed 135 in Q3 2015.
- Jacobs Levy Equity Management's portfolio value fell 7.3% quarter-over-quarter to $4.88B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.